跳至主要内容
临床试验/NCT05311007
NCT05311007已完成不适用

Intrahospital Transport in Patients With High-flow Nasal Oxygenation: Prospective Observational Study.

Centre Hospitalier Régional d'Orléans4 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2022年5月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
175
试验地点
4
主要终点
Incidence of severe adverse events during intra-hospital transport

研究概览

简要总结

High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.

There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.

Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.

The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.

详细描述

High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.

There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.

Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.

The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient treated with high-flow nasal oxygen therapy before the intra-hospital transport prior to transport
  • Requiring an intra-hospital transport (e.g., CT scan, OR, etc.) or inter-departmental transport supervised by the ICU team
  • Nb: Once the patient is included in the study, any intra-hospital transport under high-flow nasal oxygen therapy will be analyzed until discharge from the intensive care unit and at until D28.

排除标准

  • Under 18 years old
  • Patient being under guardianship, tutorship or curatorship
  • Pregnancy or breastfeeding
  • Lack of social security number
  • Refusal to participate in the study

结局指标

主要结局

Incidence of severe adverse events during intra-hospital transport

时间窗: Up to 28 days

To evaluate the incidence of severe adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Severe adverse event is defined by the occurrence of intubation during transport or severe hypoxemia defined as pulse oxygen saturation (SpO2 \< 80%) or cardiorespiratory arrest.

次要结局

  • Incidence of minor adverse events during intra-hospital transport(Up to 28 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验